Your browser doesn't support javascript.
loading
Long-Term Outcomes of Stereotactic Radiosurgery for Trigeminal, Facial, and Jugular Foramen Schwannoma in Comparison with Vestibular Schwannoma.
Shinya, Yuki; Hasegawa, Hirotaka; Shin, Masahiro; Sugiyama, Takehiro; Kawashima, Mariko; Katano, Atsuto; Kashio, Akinori; Kondo, Kenji; Saito, Nobuhito.
Affiliation
  • Shinya Y; Department of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Hasegawa H; Department of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Shin M; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Sugiyama T; Department of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Kawashima M; Diabetes and Metabolism Information Center, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Katano A; Department of Health Services Research, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
  • Kashio A; Department of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Kondo K; Department of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Saito N; Department of Otorhinolaryngology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Cancers (Basel) ; 13(5)2021 Mar 07.
Article in En | MEDLINE | ID: mdl-33799972
ABSTRACT
Stereotactic radiosurgery (SRS) is known to provide excellent tumor control with functional preservation for vestibular schwannomas (VS), but its efficacy in the other major intracranial schwannomas including trigeminal (TS), facial (FS), and jugular foramen schwannomas (JFS) has not been established yet due to their rarity. We retrospectively analyzed data of 514 consecutive patients who had intracranial schwannomas (460 VS, 22 TS, 7 FS, and 25 JFS) and underwent SRS. The 5- and 10-year tumor control rates were 97% and 94% for VS, 100% and 100% for TS, 80% and 80% for FS, and 100% and 80% for JFS. Radiation-induced complications included one hydrocephalus for TS (4.5%), no cases for FS (0%), and one hydrocephalus and one lower palsy for JFS (8.0%). Through matched cohort analysis between patients with VS and each of the non-VS, we found no statistical difference in tumor control and radiation-induced adverse events. SRS seems to provide long-term tumor control with functional preservation for TS, FS and JFS and the efficacies are similar to VS.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Japan